Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pandemic stress hits hard for arthritis patients

NCT ID NCT04798053

Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how the COVID-19 pandemic and social distancing impacted the mental health of 259 adults with chronic inflammatory rheumatism (like rheumatoid arthritis or ankylosing spondylitis). Researchers used questionnaires to measure stress, depression, anxiety, and post-traumatic stress over 6 months. The goal was to understand the psychological toll of the pandemic on this vulnerable group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could highlight the mental health needs of people with chronic inflammatory rheumatism during public health crises.
What could go wrong
This is an observational study with no treatment, so it cannot directly improve health. Results may not apply to all patients or future pandemics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

259 people

The number who actually took part.

Started

Apr 2021

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For the cases: Inclusion Criteria: * adult patient (age over 18 years old) * patient affected by a chronic inflammatory rheumatism (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Systemic lupus, Still disease, scleroderma…) * patient without any language difficulty * affiliated to an health insurance system * and who agree to participate in the study For controls : Inclusion Criteria: * adult patient (age over 18 years ol * patient affected by a non-inflammatory or degenerative musculo-skeletal disease during the containment period, * patient without any language difficulty, * affiliated to an health insurance system, * and who agree to participate in the study. For cases and controls : Exclusion Criteria: * pregnant or lactating patient * psychiatric patient * patient under guardianship or other legal protection regimen.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ankylosing spondylitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis COVID-19 mental disorder psoriatic arthritis psychiatric disorder rheumatic disorder rheumatic fever rheumatoid arthritis scleroderma systemic lupus erythematosus systemic-onset juvenile idiopathic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID19 Mental disorder Rheumatic fever

Contacts and locations

Locations

  • AP-HP - Hopital Cochin - service de rhumatologie

    Paris, France

  • AP-HP - Hopital Henri Mondor - service de rhumatologie

    Créteil, France

  • CHRU de Lille - Service de rhumatologie

    Lille, France

  • CHU de Bordeaux - service de rhumatologie

    Bordeaux, France

  • CHU de Montpellier - service de rhumatologie

    Montpellier, France

  • CHU de Saint-Etienne - service de rhumatologie

    Saint-Etienne, France

  • CHU de Toulouse - service de rhumatologie

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.